Article

CDER Drug Approvals

Author(s):

BioPharm International Editors

Drug Approvals [Includes Drug Label and Approval Letter] (Updated 12/18/2001)

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
Related Content
Industry inspector team working, QC staff work checking machine operation for safety and hygiene | Image Credit: ©Quality Stock Arts – stock.adobe.com
August 31st 2025

New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s

Patrick Falvey Georgia Sloboda Sarah DeDonder Lauren Schoukroun-Barnes
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 31st 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Ampoules vaccine from coronavirus with syringe 3d render illustration on white. | Image Credit: © mylisa - © mylisa - stock.adobe.com
August 31st 2025

FDA Approves Moderna’s Updated COVID-19 Vaccines Targeting LP.8.1 Variant

Mastering Antibody-Drug Conjugates
August 31st 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Blood sample tube contain with stem cell | Image Credit: © jarun011 - © jarun011 - stock.adobe.com
August 31st 2025

Zemcelpro Stem Cell Therapy Granted EC Conditional Marketing Authorization

Feliza Mirasol
A hand is placing the final wooden block with a green certificate checkmark, symbolizing achievement, quality assurance and completion, against a plain pastel blue background. | Image credit: TimmyTimTim – stock.adobe.com
August 31st 2025

Continued Process Verification Is Critical in Pharmaceutical Manufacturing

Philip Hoersch
© 2025 MJH Life Sciences

All rights reserved.